ALDMSP Stock Overview
Operates in the medical imaging industry in France and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Diagnostic Medical Systems S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €1.04 |
| 52 Week High | €0 |
| 52 Week Low | €0 |
| Beta | 1.19 |
| 11 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -7.97% |
| 5 Year Change | n/a |
| Change since IPO | -54.78% |
Recent News & Updates
Recent updates
Shareholder Returns
| ALDMSP | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 0% | 3.3% | 1.2% |
| 1Y | n/a | 16.3% | 11.6% |
Return vs Industry: Insufficient data to determine how ALDMSP performed against the UK Medical Equipment industry.
Return vs Market: Insufficient data to determine how ALDMSP performed against the UK Market.
Price Volatility
| ALDMSP volatility | |
|---|---|
| ALDMSP Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 5.8% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 9.2% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: ALDMSP has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ALDMSP's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | 112 | Samuel Sancerni | www.dms.com |
Diagnostic Medical Systems S.A. operates in the medical imaging industry in France. It offers radiography/fluoroscopy, retrofit kits, mammography, chest and bone rooms, mobiles, bone densitometry, 3D reconstruction, mobile C-arms, and posturology solutions. The company also exports its products.
Diagnostic Medical Systems S.A. Fundamentals Summary
| ALDMSP fundamental statistics | |
|---|---|
| Market cap | €18.62m |
| Earnings (TTM) | -€3.28m |
| Revenue (TTM) | €39.99m |
0.5x
P/S Ratio-5.7x
P/E RatioIs ALDMSP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALDMSP income statement (TTM) | |
|---|---|
| Revenue | €39.99m |
| Cost of Revenue | €24.77m |
| Gross Profit | €15.22m |
| Other Expenses | €18.50m |
| Earnings | -€3.28m |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.20 |
| Gross Margin | 38.06% |
| Net Profit Margin | -8.21% |
| Debt/Equity Ratio | 50.7% |
How did ALDMSP perform over the long term?
See historical performance and comparison